Laetrile, Hypothermia, Cancer
In this video, Gilberto Alvarez spends about 25 minutes speaking on "Laetrile, Hypothermia, Cancer" at the 38th Annual Cancer Convention held on Labor Day weekend by the Cancer Control Society.
About Dr. Gilberto Alvarez
Dr. Gilberto Alvarez is a medical doctor who graduated from the National Autonomous University in Mexico City and practices medicine in both Mexico and the United States. He has over 37 years of experience and a longtime practice in integrative and natural medicine for cancer patients. Between the years 1977 and 1981, he worked with Dr. Ernesto Contreras, a well-recognized doctor, founder of Oasis of Hope clinic in Tijuana, and the first doctor to have brought the German methods of therapy to Mexico.
Between 1982 and 1992 he was the medical director at Dr. Harold W. Manner’s clinic, pioneering in nutritional therapy based on laetrile and vitamins. Later on, Dr. Alvarez became the medical director at Stella Maris from 1993 until today. He participated on Proteolytic Enzyme Therapy in Munich, Germany with Dr. Karl Ransberger. He then became a member of the International Clinical Hyperthermia Society (ICHS) in Florence, Italy in 2005. His experience in cancer and other disorders is extensive, and he implements his expertise in different programs given at his clinic.
On a personal level, Dr. Alvarez is a warm person who sees the patient as a whole and shows genuine caring and empathy. He answers patients’ calls personally before and after treatment.
Transcription
Thank you and good evening, ladies and gentlemen. I'm going to make this presentation from the topic Lateraled therapy and hypothermia for breast, brain and prostate cancer as Stella Maris Clinic. The first half of the presentation is gonna be a dress. Everything that we do for those cancer cases that happened to show the slow growth pattern. In other words, those are not aggressive. And this is a very conservative approach. 100 percent natural. And nevertheless, I'm going to save a second part of the presentation to those cases who happen to show a relapse or those who had shown an aggressive tumor behavior. And after being the overtreated by other therapies. So I'm going to start all with the first slide here. And. And one of the main indicators or the main features that happens when the tumor becomes quite resistant has related with what is called DNA mutation or when patients are overexposed to prior radiation or chemotherapy or due to the presence of that protein, coalesce around these cancer cells. So those are presupposing factors that turn out into a cancer to become very resistant. And the meantime, quite aggressive. So let me introduce what we're doing on the first on those cases that are happened to be with a slow growth pattern. And we're split in this treatment, indro in four different areas. The first three areas which cover Siller homeostasis are natural cancer, attacking system and immunomodulators. Sieben the last one for those who happen to show on aggressive behavior or tumor with high resistance. So the first one, the the very the first thing that we are to do is to balance the patient's system. So we are to improve, to enhance the cell function and at all levels the respiratory function in the lymphatic circulatory system in order to prepare the body to be attacked but through further therapies.
Secondly, we are told, immunize this toxin that really affect the cell from good functioning. Really the this is the one that really impairs the the the the immune system. And actually, we are pretty much concentrated in eliminate these toxins and increase in the meantime are not an alkaline decision of the small intestines. Once we had created an alchemy stage out of this one, the intestines, all your Notari on the inside environment will be better absorbed through the through the intestines. And in that way, your your site is still functioning. The all the system will be in a better position to carry the load of these cancer fight. We are suitable with all these antioxidants, a like bottom and a bottom and see selenium, alpha liboi acid injectable is